Famotidine-induced acquired long QT syndrome: a case report
Famotidinin uyardığı uzun QT sendromu: olgu sunumu
Abstract views: 35
/ 
PDF downloads: 23
Keywords:
Electrocardiography, famotidine, gastritis, long QTAbstract
It is known that a number of drugs caused acquired long QT syndrome. Although the often use of famotidine, acquired long QT syndrome associated with this drug has rarely been reported. We presented a case of famotidine associated with acquired long QT syndrome.
Metrics
References
Cahoon WD Jr. Acquired QT prolongation. Prog Cardiovasc Nurs 2009;24(1):30-3.
Hulisz DT, Welko JR, Heiselman DE. Sinus arrest associated with continuous-infusion cimetidine. Pharmacotherapy 1993;13(1):64-7.
Endo T, Katoh T, Kiuchi K, Katsuta Y, Shimizu S, Takano T. Famotidine and acquired long QT syndrome. Am J Med 2000;108(5):438–9.
Lee KW, Kayser SR, Hongo RH, Tseng ZH, Scheinman MM. Famotidine and long QT syndrome. Am J Cardiol 2004;93(10):1325-7.
Gunasekaran TS, DuBrow I. Cisapride-induced long QT interval: what is the role of ranitidine? J Pediatr 1997;130(4):679-80.
Yang J, Russell DA, Bourdeau JE. Case report: ranitidineinduced bradycardia in a patient with dextrocardia. Am J Med Sci 1996;312(3):133-5.
Sugiyama A, Satoh Y, Takahara A, Nakamura Y, ShimizuSasamata M, Sato S, et al. Famotidine does not induce long QT syndrome: experimental evidence from in vitro and in vivo test systems. Eur J Pharmacol 2003;466(1-2):137-46.
Kenigsberg DN, Khanal S, Kowalski M, Krishnan SC. Prolongation of the QTc interval is seen uniformly during early transmural ischemia. J Am Coll Cardiol 2007;49(12):1299-305.
Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30(2):239-45.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 European Journal of Therapeutics
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
